Skip to main content
. 2022 Jun 17;17(3):283–293. doi: 10.1007/s11523-022-00888-9

Fig. 2.

Fig. 2

Mean (±SD) plasma concentration-time profiles for cobimetinib following a single dose (cycle 1 Day 1) and b multiple dose (cycle 1 Day 21) administration of oral suspension formulations. SD standard deviation